首页 | 本学科首页   官方微博 | 高级检索  
     


A clean‐up technology for the simultaneous determination of lysophosphatidic acid and sphingosine‐1‐phosphate by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry using a phosphate‐capture molecule,Phos‐tag
Authors:Jun‐ichi Morishige  Mai Urikura  Haruko Takagi  Kaoru Hirano  Tohru Koike  Tamotsu Tanaka  Kiyoshi Satouchi
Affiliation:1. Research Center for Green Science, Fukuyama University, Fukuyama 729‐0292, Japan;2. Department of Applied Biological Science, Fukuyama University, Fukuyama 729‐0292, Japan;3. Department of Functional Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734‐8551, Japan
Abstract:Lysophosphatidic acid (LPA) and sphingosine‐1‐phosphate (S1P) are growth factor‐like lipids having a phosphate group. The concentrations of these mediator lipids in blood are considered to be potential biomarkers for early detection of cancer or vascular diseases. Here, we report a method for simultaneous determination of LPA and S1P using Phos‐tag, a zinc complex that specifically binds to a phosphate‐monoester group. Although both LPA and S1P are hydrophilic compounds, we found that they acquire hydrophobic properties when they form complexes with Phos‐tag. Based on this finding, we developed a method for the enrichment of LPA and S1P from biological samples. The first partition in a two‐phase solvent system consisting of chloroform/methanol/water (1:1:0.9, v/v/v) is conducted for the removal of lipids. LPA and S1P are specifically extracted as Phos‐tag complexes at the second partition by adding Phos‐tag. The Phos‐tag complexes of LPA and S1P are detectable by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOFMS) and quantifiable based on the relative intensities of ions using 17:0 LPA and C17 S1P as internal standards. The protocol was validated by analyses of these mediator lipids in calf serum, a rat brain and a lung. The clean‐up protocol is rapid, requires neither thin‐layer chromatography (TLC) nor liquid chromatography (LC), and is applicable to both blood and solid tissue samples. We believe that our protocol will be useful for a routine analysis of LPA and S1P in many clinical samples. Copyright © 2010 John Wiley & Sons, Ltd.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号